SEC 13F Intelligence

Privium Fund Management B.V. / ESPR

Privium Fund Management B.V.’s Esperion Therapeutics Inc Ne Position

Does Privium Fund Management B.V. own Esperion Therapeutics Inc Ne (ESPR)? Yes3.30M shares worth $9M (+1.88% of its 13F portfolio) as of Q1 2026.

Position Value
$9M
Q1 2026
Shares
3.30M
% of Portfolio
+1.88%
Quarters Held
1
currently held

Position History ESPR

Reported value by quarter
Q1 ’26: $9MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.30M$9M+1.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Privium Fund Management B.V.’s full portfolio or all institutional holders of ESPR.